ALS Association yearly report cards show no U.S. state earned the highest score for policies supporting patients; several had ...
As guest writer Nancy Muirhead's ALS progresses, she decides to leave a legacy of love by writing letters to all of her ...
In carrying on her late husband's tradition of feeding wildlife, columnist Juliet Taylor realizes that her actions are a way of honoring him.
An inflammatory sugar molecule produced by certain gut bacteria may play a key role in driving ALS, a study found.
A dream in the night takes columnist Kristin Neva back to when she and her husband, Todd, were free from ALS hanging over their heads.
ALS ONE will join the ALS Network to expand ALS research efforts, improve patient services, and strengthen nationwide ...
The rollator industry is overdue for a transformation, says columnist Dagmar Munn, a longtime user of the device who is living with ALS.
A study is exploring why athletes, first responders, and other high performers face an increased risk of developing ALS.
The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results